Adam Lankowski
Israelbusiness executiveMale7.0Global Dominance: 0.00%Adam Lankowski is a commercialization manager at Bristol Myers Squibb, where he oversees the development and market introduction of innovative therapies, including the oral medication Mazigdomide, which is being studied for its potential to improve treatment outcomes for patients with multiple myeloma.
Power1,389
Reach32,003
Country presence
Recent news mentions
Adam Lankowski, a commercialization manager at Bristol Myers Squibb, mentioned that doctors are excited about the new oral treatment.
פריצת דרך בטיפול בסרטן הדםידיעות אחרונות (Yedioth Ahronoth / ynet)·Israel· 2026-06-01
Israel· 2026-06-01
